EP0628076A1
(en)
*
|
1992-11-19 |
1994-12-14 |
GINGERAS, Thomas R. |
PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA
|
EP0682121B1
(en)
*
|
1993-12-01 |
2002-08-28 |
Toyo Boseki Kabushiki Kaisha |
Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
|
US5705366A
(en)
*
|
1994-09-15 |
1998-01-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
|
JPH08131171A
(ja)
*
|
1994-11-11 |
1996-05-28 |
Asahi Chem Ind Co Ltd |
逆転写酵素の安定化組成物
|
US5763184A
(en)
|
1996-01-30 |
1998-06-09 |
Roche Molecular Systems, Inc. |
Nucleotide sequence variation in the ABO glycosyltransferase gene
|
WO2000000638A2
(en)
*
|
1998-06-26 |
2000-01-06 |
Akzo Nobel N.V. |
Tagging of rna amplicons generated by transcription-based amplification
|
JP2001029078A
(ja)
*
|
1999-07-16 |
2001-02-06 |
Shimadzu Corp |
Rna増幅法
|
WO2002012263A1
(en)
|
2000-08-03 |
2002-02-14 |
Roche Diagnostics Gmbh |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
US6780588B2
(en)
|
2001-05-07 |
2004-08-24 |
Applera Corporation |
Methods for the reduction of stutter in microsatellite amplification
|
US6841349B2
(en)
|
2001-05-07 |
2005-01-11 |
Applera Corporation Applied Biosystems Group |
Methods for the reduction of stutter in microsatellite amplification
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US9777312B2
(en)
|
2001-06-30 |
2017-10-03 |
Enzo Life Sciences, Inc. |
Dual polarity analysis of nucleic acids
|
US9261460B2
(en)
|
2002-03-12 |
2016-02-16 |
Enzo Life Sciences, Inc. |
Real-time nucleic acid detection processes and compositions
|
WO2003057910A2
(en)
|
2002-01-08 |
2003-07-17 |
Roche Diagnostics Gmbh |
Use of silica material in an amplification reaction
|
US7122314B2
(en)
|
2002-01-30 |
2006-10-17 |
Id Biomedical Corporation |
Methods for detecting vancomycin-resistant microorganisms and compositions therefor
|
US9353405B2
(en)
|
2002-03-12 |
2016-05-31 |
Enzo Life Sciences, Inc. |
Optimized real time nucleic acid detection processes
|
DE10240868A1
(de)
*
|
2002-09-04 |
2004-03-18 |
Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH |
Verbesserte Verfahren zur Synthese von Nukleinsäuren
|
DE602004009038T3
(de)
|
2003-01-29 |
2015-06-25 |
Roche Diagnostics Gmbh |
Verbessertes Verfahren zur Behandlung durch Bisulfit
|
JP2004357502A
(ja)
*
|
2003-05-30 |
2004-12-24 |
Olympus Corp |
核酸分子を使用した情報処理方法
|
WO2006006722A1
(ja)
|
2004-07-13 |
2006-01-19 |
Takeda Pharmaceutical Company Limited |
細胞機能の調節方法
|
EP1632578A1
(en)
|
2004-09-03 |
2006-03-08 |
Roche Diagnostics GmbH |
DNA decontamination method
|
GB0701253D0
(en)
|
2007-01-23 |
2007-02-28 |
Diagnostics For The Real World |
Nucleic acid amplification and testing
|
AU2008283902B2
(en)
|
2007-08-06 |
2014-03-13 |
Orion Genomics Llc |
Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
|
CA2639416C
(en)
|
2007-09-11 |
2019-12-31 |
F. Hoffmann-La Roche Ag |
Diagnostic test for susceptibility to b-raf kinase inhibitors
|
AU2008318316B2
(en)
|
2007-11-01 |
2015-08-06 |
University Of Iowa Research Foundation |
RCA locus analysis to assess susceptibility to AMD and MPGNII
|
EP2396429B1
(en)
|
2009-02-11 |
2015-05-27 |
Orion Genomics, LLC |
Combinations of polymorphisms for determining allele-specific expression of igf2
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
US20130143214A1
(en)
|
2010-06-04 |
2013-06-06 |
Chronix Biomedical |
Prostate cancer associated circulating nucleic acid biomarkers
|
US20140004510A1
(en)
|
2010-09-24 |
2014-01-02 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for prognosing and/or detecting age-related macular degeneration
|
US9458484B2
(en)
|
2010-10-22 |
2016-10-04 |
Bio-Rad Laboratories, Inc. |
Reverse transcriptase mixtures with improved storage stability
|
EP2751280B1
(en)
|
2011-08-31 |
2016-06-29 |
F.Hoffmann-La Roche Ag |
Method for predicting risk of hypertension associated with anti-angiogenesis therapy
|
WO2013030167A1
(en)
|
2011-08-31 |
2013-03-07 |
F. Hoffmann-La Roche Ag |
Responsiveness to angiogenesis inhibitors
|
KR20140064971A
(ko)
|
2011-09-19 |
2014-05-28 |
제넨테크, 인크. |
c-met 길항제 및 B-raf 길항제를 포함하는 조합 치료
|
US20140303008A1
(en)
|
2011-10-21 |
2014-10-09 |
Chronix Biomedical |
Colorectal cancer associated circulating nucleic acid biomarkers
|
EP2783015A1
(en)
|
2011-11-23 |
2014-10-01 |
F.Hoffmann-La Roche Ag |
Responsiveness to angiogenesis inhibitors
|
US9115394B2
(en)
|
2011-12-22 |
2015-08-25 |
Roche Molecular Systems, Inc. |
Methods and reagents for reducing non-specific amplification
|
US20160115541A1
(en)
|
2013-05-29 |
2016-04-28 |
Chronix Biomedical |
Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
|
KR20160138494A
(ko)
|
2014-03-31 |
2016-12-05 |
데비오팜 인터네셔날 에스 에이 |
Fgfr 융합물
|
US20160168640A1
(en)
|
2014-11-10 |
2016-06-16 |
Genentech, Inc. |
Therapeutic and diagnostic methods for il-33-mediated disorders
|
ES2961374T3
(es)
|
2015-04-24 |
2024-03-11 |
Atila Biosystems Incorporated |
Amplificación con cebadores de composición de nucleótidos limitada
|
PT3640345T
(pt)
|
2015-08-17 |
2021-12-29 |
Kura Oncology Inc |
Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
|
US20190119758A1
(en)
|
2016-04-22 |
2019-04-25 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
DK3534885T3
(da)
|
2016-11-03 |
2021-04-12 |
Kura Oncology Inc |
Farnesyltransferase-inhibitorer til anvendelse i behandling af kræft
|
EP3432883B1
(en)
|
2017-02-21 |
2021-07-28 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
US10137121B2
(en)
|
2017-02-21 |
2018-11-27 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
MY200746A
(en)
|
2017-08-07 |
2024-01-13 |
Kura Oncology Inc |
Methods of treating cancer with farnesyltransferase inhibitors
|
US10806730B2
(en)
|
2017-08-07 |
2020-10-20 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
KR20230142806A
(ko)
|
2018-02-09 |
2023-10-11 |
제넨테크, 인크. |
비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법
|
CA3117968A1
(en)
|
2018-11-01 |
2020-05-07 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
US20220142983A1
(en)
|
2019-03-01 |
2022-05-12 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
CN113795253A
(zh)
|
2019-03-29 |
2021-12-14 |
库拉肿瘤学公司 |
用法呢基转移酶抑制剂治疗鳞状细胞癌的方法
|
TW202102218A
(zh)
|
2019-04-01 |
2021-01-16 |
美商庫拉腫瘤技術股份有限公司 |
以法呢基(farnesyl)轉移酶抑制劑治療癌症的方法
|
US20220305001A1
(en)
|
2019-05-02 |
2022-09-29 |
Kura Oncology, Inc. |
Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
|
US20230110203A1
(en)
|
2020-03-13 |
2023-04-13 |
Medimmune Limited |
Therapeutic methods for the treatment of subjects with risk alelles in il33
|
WO2024015331A1
(en)
|
2022-07-12 |
2024-01-18 |
Genentech, Inc. |
Therapeutic and diagnostic methods for multiple sclerosis
|